Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

NCT04130828 is registered in ClinicalTrials.gov with Prince of Songkla University as lead sponsor.

NCT NCT04130828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04130828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia
Lead sponsor
Prince of Songkla University
Phase
Phase 3
Overall status
Completed
Start date
January 21, 2020
Completion date
January 18, 2022
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia